간동맥 화학색전술 후 간암 환자의 통증관리와 통증 영향요인
The Factors of Pain and Pain Management after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to identify the factors of pain and pain management after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). Methods: Participants were 99 inpatients with HCC who underwent TACE at C University in Seoul from May to October 2016. The instruments used in this study were the Numerical Rating Scale (NRS), the Pain Management Index (PMI), and the modified Patient Outcome Questionnaire (American Pain Society). The data were analyzed using SPSS 24.0, specifically descriptive statistics, t-test, ANOVA, and multiple regression. Results: The percentage of patients who experienced pain after TACE was 66.7%. The mean pain score immediately after TACE was 4.43±2.36 and the highest score on average was 6.58±2.32. The pain score was highest at 5.24±5.67 hours after TACE. Significant factors influencing pain after TACE were the extent of embolization and the ECOG (Eastern Cooperative Oncology Group) score, which explained 26% of the variance in pain. PMI scores revealed that 33.3% of the participants were inadequately treated for pain. Conclusion: In order to properly manage pain after TACE, medical staff need accurate understanding of pain and to administer the appropriate dosage of analgesics. The development of pain management protocol for patients who have undergone TACE would help achieve these goals.
Abstract
Purpose: The purpose of this study was to identify the factors of pain and pain management after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). Methods: Participants were 99 inpatients with HCC who underwent TACE at C University in Seoul from May to October 2016. The instruments used in this study were the Numerical Rating Scale (NRS), the Pain Management Index (PMI), and the modified Patient Outcome Questionnaire (American Pain Society). The data were analyzed using SPSS 24.0, specifically descriptive statistics, t-test, ANOVA, and multiple regression. Results: The percentage of patients who experienced pain after TACE was 66.7%. The mean pain score immediately after TACE was 4.43±2.36 and the highest score on average was 6.58±2.32. The pain score was highest at 5.24±5.67 hours after TACE. Significant factors influencing pain after TACE were the extent of embolization and the ECOG (Eastern Cooperative Oncology Group) score, which explained 26% of the variance in pain. PMI scores revealed that 33.3% of the participants were inadequately treated for pain. Conclusion: In order to properly manage pain after TACE, medical staff need accurate understanding of pain and to administer the appropriate dosage of analgesics. The development of pain management protocol for patients who have undergone TACE would help achieve these goals.
참고문헌 (29)
- "Cancer statistics. mortality rate 2015"[URL]
- "Cancer registration statistics 2010"[URL]
- 한승호, "간세포암종 환자의 새로운 예후 지표 - Modified CLIP Score -", Clinical and Molecular Hepatology, 12(2), pp.209~220 (2006), 대한간학회
- 정진욱, "간동맥 색전술의 발전", 대한의사협회지, 56(11), pp.972~982 (2013), 대한의사협회
- Yoo SH, "Complications associated with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma", J Korean Liver Cancer Study Group, 11, pp.144~148 (2011)
- 이근호, "간세포암 치료에서 수술 전 간동맥 화학색전술의 효과", 대한내과학회지, 70(1), pp.17~25 (2006), 대한내과학회
- Jeong YH, "Effective treatment of early diagnosis hepatocellular carcinoma", J Radiol Sci Technol, 27, pp.5~11 (2004)
- Hwang JS, "Predisposing factors of complications in the treatment of hepatocellular carcinoma", Korean J Hepatol, 13, pp.63~69 (2007)
- Kim KH, "Prospective analysis of complications of transarterial chemolipiodolization in patients with hepatocellular carcinoma", Korean J Gastroenterol, 33, pp.815~822 (1999)
- Jee SR, "Complications and risk factors after transcatheter arterial chemoembolizaion in the patients with hepatocellular carcinoma", pp.2000
- Cao W, "Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China", Support Care Cancer, 21, pp.475~483 (2013)
- Kim MG, "Evaluation of the effect of pain relief within the hepatic artery injection Lidocaine for reducing abdominal pains caused by TACE", J Korean Soc Interv Radiol, 14, pp.199~205 (2011)
- Zhou B, "Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE", Radiology, 262, pp.1014~1021 (2012)
- Prajapati HJ, "Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization", J Vasc Interv Radiol, 23, pp.1286~1293 (2012)
- Jang YJ, "Post operative pain of spinal surgery patients’ and satisfaction about intervention of pain control", pp.2004
- Woo JS, "Postoperative pains and the actual conditions of pain manage ment and satisfaction with pain control for elderly operative patients", pp.2007
- Kim NH, "The effects of aromatherapy to reduce nausea vomiting and pain in patients receiving transcatheter arterial chemoembolization", pp.2010
- 윤미정, "체위변경이 간동맥 화학색전술 환자의 요통, 불편감, 출혈합병증에 미치는 효과", 성인간호학회지, 26(4), pp.424~433 (2014), 한국성인간호학회[DOI]
- Max MB, "Quality improvement guidelines for the treatment of acute pain and cancer pain", JAMA, 274, pp.1874~1880 (1995)
- Kwon IG, "Effects of education on pain management provided to cancer patients and medical personnel", pp.1999
- Lee SH, "Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration", Cardiovasc Intervent Radiol, 24, pp.368~371 (2001)
- Malagari K, "Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients", Cardiovasc Intervent Radiol, 34, pp.774~785 (2011)
- 정은영, "효율적인 돌발성 암 통증 관리를 위한 자가 진단 알고리즘 설계", 한국콘텐츠학회 논문지, 14(5), pp.458~467 (2014), 한국콘텐츠학회[DOI]
- 송숙연, "자궁근종과 자궁선근증 치료를 위한 자궁동맥색전술 후 24시간 이내의 통증 조절에 대한 경피 펜타닐 패치의 효과", 대한영상의학회지, 64(5), pp.449~455 (2011), 대한영상의학회
- Wáng YX, "Transcatheter embolization therapy in liver cancer: an update of clinical evidences", Chin J Cancer Res, 27, pp.96~121 (2015)
- Leung DA, "Determinants of postembolization syndrome after hepatic chemoembolization", J Vasc Interv Radiol, 12, pp.321~326 (2001)
- Narayanan G, "Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer", Anticancer Res, 33, pp.2077~2083 (2013)
- Feng YL, "Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial", Zhong Xi Yi Jie He Xue Bao, 3, pp.99~102 (2005)
- Yinglu F, "A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization", J Altern Complement Med, 15, pp.175~181 (2009)